Corpus Intelligence Deal Quality 2026-04-26 10:17 UTC
Deal Quality
655 deals scored · avg quality 73.3/100 · A:313 B:338 C:4 D:0 · 41 flagged
🛡️ Public data only — no PHI permitted on this instance.
Total Deals
655
in corpus
Avg Quality
73.3
out of 100
Tier A
313
48% of corpus
Tier B
338
52% of corpus
Flagged
41
4 errors total
Quality Distribution
A:313B:338
A≥75 · B≥55 · C≥35 · D<35  |  composite = 55% completeness + 45% credibility
0102030405060708090med=72
Per-Deal Quality Scores — 13 of 313
ID Deal Tier Score Completeness Credibility Flags Missing Fields
seed_390 Pivot Health / Deerfield acquisition + A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_397 CareMore Health / Anthem acquisition A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_405 Omada Health / Andreessen Horowitz gro A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_414 BioSig Technologies / cardiac electrop A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_418 Nant Health / Patrick Soon-Shiong grow A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_420 CASI Pharmaceuticals / Chinese market A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_425 IPC Systems / CareMore merger (telehea A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_428 NovaBay Pharmaceuticals / Wound care s A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_429 Spring Health / General Catalyst growt A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_432 Healtheon / WebMD Health merger (origi A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_440 Radiology Partners / New Enterprise As A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_448 MedBridge / TA Associates physical the A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
seed_452 Caliber Imaging / pathology AI growth A 75.2 55% 100% ebitda_at_entry_mm, ebitda_mm, ev_ebitda, region, state…
1234567
Scoring Methodology
sector20 pts
ebitda_at_entry_mm18 pts
year10 pts
source8 pts
ebitda_mm / ev_ebitda8 / 7 pts
deal_type / region / revenue6 / 6 / 5 pts
geography / state / leverage / notes4/3/3/2 pts
Start score100
MOIC ≤ 0 (error)−30
IRR < −100% (error)−20
EV ≤ 0 (error)−25
Hold ≤ 0 (error)−15
MOIC/IRR mismatch >25pp−10
EV/EBITDA outside 2–40×−8